Resorbable Implants Market - Forecast(2024 - 2030)

Resorbable Implants Market Overview

Resorbable Implants Market Size is estimated to reach $11.5 billion by 2027. Furthermore, it is poised to grow at a CAGR of 7.6% over the forecast period of 2022-2027. Resorbable implants are mainly used in areas or organs of the human body that lack self-generation capacity and hence require the support of the following implants. Furthermore, the following implants are made of Polymers such as Polylactic acid, Polydioxanone, and Polyglycolic acid, which can be dissolved or absorbed by the body over time. As a result, the following implant does not need to be removed after a certain period of time. It is presently employed in a variety of applications, including dental procedures and other orthopedic operations, owing to the following qualities. Researchers are also evaluating material developments such as the utilization of zinc, iron, and magnesium to see if they may be used as bioresorbable cardiovascular stents. They do away with the necessity for extra surgery to remove a sensor or other functioning component that is no longer required. Since biodegradable devices are designed to be implanted in the brain or other organs deep within the body, this is very significant. These implants can also be utilized to distribute drugs or heal tissue.

The aging population has grown in importance across regions, and the multi-accessible use of the implants in a variety of applications is one of the drivers propelling the resorbable implant industry forward from 2022 to 2027.

Resorbable Implants Market Report Coverage

The report: “Resorbable Implants Market Forecast (2022-2027)", by Industry ARC covers an in-depth analysis of the following segments of the Resorbable Implants Market.

By Product Type- Resorbable Stent, Resorbable Mesh, Resorbable Band, Resorbable Scaffolds, and Resorbable Tethers.
By Material Type- Polyglycolic Acid, Polylactic Acid, Polydioxanone, Poly-L-Lactic Acid, Poly-D Lactic Acid, Polycaprolactone, and Poly beta-hydroxybutyrate.
By Application- Cardiovascular Surgery, Orthopedic Surgery, Dental Surgery, Vascular Surgery, and General Surgery.
By End User- Hospitals, Cardiology Clinics, Orthopedic Clinics, Ambulatory Surgical Centers & Others.
By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, Chile, Colombia, and Rest of South America), and Rest of the World (the Middle East, and Africa).

Key Takeaways

• Geographically, North America held a dominant market share in the year 2021 on account of a strong medical infrastructure in place to treat a variety of diseases, as well as essential manufacturers in the industry. Asia-Pacific is estimated to offer lucrative growth opportunities to the manufacturers owing to a rise in demand for implants made from polymers. The proliferation of Rheumatoid arthritis is predicted to augment the market growth during the forecast period of 2022-2027.
• The market will be driven by the increased adoption of bio-resorbable implant types, which will be aided by major technological advancements. However, adverse case reactions based on the immune response have posed a market hurdle.
• A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Resorbable Implants Market Report.

Resorbable Implants Market Segmentation Analysis- By Material Type

Resorbable Implants Market based on the material type can be further segmented into Polyglycolic Acid, Polylactic Acid, Polydioxanone, Poly-L-Lactic Acid, Poly-D Lactic Acid, Polycaprolactone, and Poly beta-hydroxybutyrate. Poly-L-Lactic Acid held a dominant market share in the year 2021. As per Elsevier, in 2019, Poly Lactic Acid (PLA) is a biopolymer that can be used in a variety of applications. PLA is simple to make and biodegradable, since of abundant renewable resources. PLA has shown potential in a variety of healthcare applications, including tissue engineering and regenerative medicine, cardiovascular implants, dental niches, drug carriers, orthopedic treatments, cancer therapy, skin and tendon mending, and medical tools and equipment. PLA has proved its value as a three-dimensional (3D) printable biopolymer, which has been supported by its participation in the global pandemic of Coronavirus Disease 2019 (Covid-19). PLA's abundance has resulted in the development of much-needed personal protection equipment (PPE) and ventilation adjustments. PLA-based modalities will continue to evolve as polymer chemistry advances, as will their uses and efficacy. The high PLA market is owing to the chemical feature of the following acid class. Polylactic acid can be naturally transformed into lactic acid by the body's enzymatic response, according to numerous research. Furthermore, the excretory systems of the body can safely remove them. In terms of biological safety, according to data from the United States on fatal car accidents in 2019, 33,244 persons required immediate medical assistance owing to bone fractures, ligament tears, or other diseases. In comparison to co-polymers such as polyglycolic acid and polycaprolactone, polylactic acid is a beneficial material for addressing the following instances, metabolite properties. Hence, the Poly-L-Lactic Acid category, on the other hand, is estimated to increase at the quickest rate, with a CAGR of 8.3% over the projected period. This is owing to the rise in the adoption of resorbable Poly-L-lactic acid-polyglycolic acid implants and bone cement for treating large orbital floor fractures.

Resorbable Implants Market Segmentation Analysis- By End User

The Resorbable Implants Market based on the end user can be further segmented into Hospitals, Cardiology Clinics, Orthopaedic Clinics, Ambulatory Surgical Centres & Others. Hospitals held a dominant market share in the year 2021 and are estimated to be the fastest-growing, with a CAGR of 8.1% over the forecast period of 2022-2027. The rationale for the increased use of hospitals is that hospital facilities outnumber the other two in terms of number. There are 2-3 orthopedic clinics and ambulatory surgical centers for every ten hospitals. According to the American Academy of Orthopaedic Surgeons, in 2020, Current implant designs take into account the joint's complexity and more nearly resemble the motion of a natural knee. Ligaments, for example, keep the joint stable in a healthy knee. Some implant designs keep the patient's natural ligaments intact, while others replace them. Knee implants are made by a number of companies, and there are over 150 different designs available today.

Resorbable Implants Market Segmentation Analysis- By Geography

The Resorbable Implants Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held a dominant market share of 31% in the year 2021 as compared to the other counterparts on account of the region's high healthcare spending. According to the Centers for Medicare and Medicaid Services, 2021, From 2019 through 2028, national health spending is estimated to climb at a 5.4 percent annual rate, reaching $6.2 trillion. The health portion of the economy is estimated to climb from 17.7% in 2018 to 19.7% in 2028, as national health expenditures are estimated to grow 1.1 percentage points faster each year on average than gross domestic product between 2019 and 2028. The following factors, combined with strong medical enterprises, have helped the region to become dominant.

However, Asia-Pacific is estimated to be the fastest-growing over the forecast period of 2022-2027 on account of expenditures for medical infrastructure being allocated at an exponential rate in the regions. India, for example, had a 136% increase in medical costs in 2019 compared to the previous year. Furthermore, Korea has a reputation for being a forerunner in medical innovation. The following factors, together with the growing geriatric population, will propel the market forward at a rapid pace.

Resorbable Implants Market Drivers

The Rising Geriatrics Population is driving the market for Resorbable Implants

According to current market trends, the senior population will expand. The changes are more pronounced in high HDI countries like Korea and the United States. According to a recent US CDC prediction, the elderly and younger populations will equalize by 2036, with the former increasing exponentially after that. Researchers believe that the senior population, particularly those over 65, is more likely to have surgeries in any of the following areas: hip replacement surgery, knee replacement surgery, shoulder replacement surgery, and spinal surgery. We are well recognized that resorbable implants are commonly used in orthopedic treatments, therefore this trend will benefit the market. Hip fractures are one of the most common catastrophic injuries among the elderly, and they frequently necessitate emergency surgery and anesthetic. Patients may stay in the hospital for several weeks, resulting in 1.5 million hospital bed days used each year. According to NICE guidelines, surgery should be performed on the same day as admission to the hospital or the next day. This is since being confined to a bed with a hip fracture is inconvenient, humiliating, and distressing, and patients are unable to get out of bed until the operation is completed. Hence, the Rising Geriatrics population is driving the market for Resorbable Implants

The Rising Prevalence of Osteoporosis and Cardiovascular Disorders is propelling the market

Cardiovascular diseases (CVDs) will be the leading cause of death in 2021, according to the World Health Organization (WHO), killing an estimated 17.9 million people each year. Coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other heart and blood vessel problems are all examples of CVDs. Heart attacks and strokes account for more than four out of every five CVD deaths which need surgeries. According to the International Osteoporosis Foundation, in 2020, Each year, osteoporosis causes more than 8.9 million fractures worldwide, with an osteoporosis fracture occurring every three seconds. As per the World Health Organization's definition of osteoporosis, the condition affects around 6.3 percent of men over 50 and 21.2 percent of women in the same age group worldwide. Based on the global male and female population, this means that around 500 million men and women may be affected. In 2019, 32 million people aged 50 and up in Europe (European Union plus Switzerland and the United Kingdom) are estimated to have osteoporosis, accounting for 5.6 percent of the total European population aged 50 and up, or roughly 25.5 million women. In the year 2000, an estimated 9 million new osteoporosis fractures were reported, with 1.6 million hip fractures, 1.7 million forearm fractures, and 1.4 million clinical vertebral fractures. The Western Pacific region and Southeast Asia accounted for the majority of the remaining fractures, with Europe and the Americas accounting for 51% of all fractures. Hence, the rising prevalence of osteoporosis and cardiovascular diseases is rising the use of implants since most of the diseases need surgeries.

Resorbable Implants Market Challenges

Adverse Effects owing to Resorbable Implants are restraining the market

The most prevalent type of immunological response to implants is metal sensitivity. Stainless steel (with nickel), cobalt, chromium, and titanium are the most frequent metals used in orthopedic and dental implants. Nitinol is used to make cardiac stents and patches (an alloy of titanium and nickel). Metal allergies are becoming more common in the general population, owing to increased exposure to the metal via piercings, jewelry, and internal medical equipment or dental restorations. Metal alloys such as nickel, cobalt, chromium, molybdenum, zirconium, and titanium are commonly used in medical implants. Nickel, cobalt, and chromium sensitivity affect up to 13% of people; nickel allergies affect 17% of women and 3% of men, while 1-2 percent of persons is allergic to cobalt, and chromium, or both. It's not unestimated, then, that immunological responses to medical implants, such as hypersensitivity to pacemakers or other cardiovascular devices, cranial endovascular stents and coils, dental implants, and orthopedic hardware, are frequently documented in the literature (eg, joint replacement prostheses, fracture fixation devices, and pain-relief stimulators). The immune system reacts to surface alterations and breakdown products when implants corrode or degrade. The presence of corrosion products and a hypersensitive reaction in patients, according to Huber et al, suggests that there is a link between corrosion and implant-related hypersensitivity. Thus, Adverse effects owing to Resorbable Implants are restraining the market.

Resorbable Implants Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Resorbable Implants Market. The top 10- Resorbable Implants Market companies are-

1. Bionx Implants Inc.
2. Tornier, Inc.
3. Degradable Solutions AG
4. Integra Life Sciences Corporation
5. Proxy Biomedical Ltd.
6. KLS Martin LP.
7. Johnson & Johnson Services
8. Abbott Medicals
9. Reva Medicals
10. Biotronik SE & Co.

Recent Developments

• In July 2021, Tornier, Inc. launched the Tornier Perform® Humeral Stem. The Tornier Perform Humeral Stem was created with four collar diameters and varying lengths in mind to optimize humeral fit and provide surgeons the power to perform while also giving them options. It's appropriate for treating smaller patient anatomies that provide unique issues since it focuses on smaller stem alternatives. To accommodate the patient's individual anatomy, the Tornier Perform Humeral Stem is compatible with the full array of standard and augmented Perform glenoid options—for anatomic and reversing surgeries. Blueprint planning software helps surgeons to plan their Perform cases ahead of time and simulates real-time, precision surgery for enhanced assurance before entering the operating room.
• In July 2021, Abbott launched a medical device named Amplatzer Piccolo Occluder. It promises to be the world's first medical device for treating patent ductus arteriosus, or PDA, that can be implanted in the tiniest of babies (weighing as little as 700 gm) via a minimally invasive process. The Amplatzer Piccolo Occluder, a device the size of a pea, provides hope to premature infants and newborns who require corrective treatment, are non-responsive to medicine, and are at high risk of requiring corrective surgery.
• In January 2020, Biotronik SE & Co. launched BIOMONITOR III; The new technology is intended to aid patients with abnormal heart rhythms by better recording unexplained syncope. BIOTRONIK's new ICM aims to improve the accuracy of arrhythmia detection and diagnosis by improving signal quality. The long vector design of this innovative gadget has the ability to record not only the ventricular but also the atrial waves on the subcutaneous ECG, allowing for a more accurate diagnosis.

Relevant Titles

Dental Implants Market - Forecast(2022 - 2027)

Report Code: HCR 1300

Neuroprosthetics Market - Forecast(2022 - 2027)

Report Code: HCR 0346

Breast Implants Market - Forecast(2022 - 2027)

Report Code: HCR 1159

For more Lifesciences and Healthcare Market reports, please click here